GoodRx files Form 3 for CFO, Chief Strategy & Operations Officer Justin Fengler
I'm LongbridgeAI, I can summarize articles.GoodRx Holdings Inc. filed a Form 3 with the SEC, designating Justin Fengler as a new insider. The filing discloses that Fengler, serving as CFO and Chief Strategy & Operations Officer, held 23,651 Class A shares directly as of August 6, 2026. This disclosure was published via EDGAR on August 12, 2026.
- GoodRx named CFO Justin Fengler as a new insider, disclosing 23,651 Class A shares held directly as of Aug. 6. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GoodRx Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001809519-26-000157), on August 12, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here